Bard Associates’s AMREP Corp AXR Stock Holding History

Bard Associates’s Portfolio AXR Stock Details AXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,000	Closed	-$63K	–	163
2019 Q1	$63K	Hold	11,000	–	–	0.03%	156
2018 Q4	$65K	Hold	11,000	–	–	0.04%	162
2018 Q3	$80K	Hold	11,000	–	–	0.04%	162
2018 Q2	$78K	Hold	11,000	–	–	0.04%	163
2018 Q1	$79K	Buy	+11,000	New	+$80.5K	0.04%	164

Other funds holding AXR

Robotti Robert $641M AUM 66.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AWW

Alan W. Weber $336M AUM 75.94% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Oppenheimer & Close New York $159M AUM 60.56% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bard Associates's AXR Position: Q2 2019 in Review

Bard Associates sold out of AMREP Corp (AXR) in Q2 2019, closing a stake of 11,000 shares — an estimated $63K sold.

Bard Associates first reported a position in AXR in Q1 2018 and held it in 5 quarters. The position peaked at $80K in Q3 2018. 17 funds tracked by Wall St. Rank hold AXR as of Q2 2019.

Bard Associates reported no remaining AMREP Corp position as of Q2 2019 after selling out during the quarter.
Bard Associates sold 11,000 AMREP Corp shares in Q2 2019, an estimated $63K.
Bard Associates first reported a position in AMREP Corp in Q1 2018 and held it in 5 quarters.
Bard Associates's AMREP Corp position peaked at $80K in Q3 2018.
17 funds tracked by Wall St. Rank held AMREP Corp as of Q2 2019.

Based on Bard Associates's 13F filing for Q2 2019, filed 13 Aug 2019.